JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHAYER, R. W.
Right arrow Articles by REILLY, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHAYER, R. W.
Right arrow Articles by REILLY, M. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 177, Issue 1, 177-180, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF DECABORANE ON HISTAMINE FORMATION IN MICE

RICHARD W. SCHAYER 1 and MARGARET A. REILLY 1

1 Research Center, Rockland State Hospital, Orangeburg, New York

Decaborane (B10H14) has been reported to inhibit stomach histidine decarboxylase in rats, to reduce brain histamine in several species and to reduce histamine levels in stomach and urine of rats (Medina et al. J. Pharmacol. Exp. Ther. 169: 132-137, 1969). We have extended these studies with mice. One day after injection of decaborane mice were either sacrificed and histidine decarboxylase of stomach and brain was tested, or injected with 14C-l-histidine and 14C-histamine was measured at intervals suitable for each tissue. We found 1) strong inhibition of histidine decarboxylase from stomach and brain, 2) a marked reduction of in vivo histamine formation in skin and a moderate reduction in brain and 3) enhanced histamine formation in stomach. We agree with Medina et al. that decaborane is the first substance shown capable of in vivo inhibition of brain histamine formation; however, we feel that the reduced histamine levels they observed in stomach and urine might be due to factors other than inhibition of histidine decarboxylase. Other aspects of a decaborane-histamine interaction are discussed.

Submitted on October 31, 1970
Accepted on December 8, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.